首页> 外国专利> Preparing imidazolium salts, preferably 1,3-disubstiuted imidazolium salts, useful e.g. as precursors of N-heterocyclic carbenes, comprises reducing 1,3-disubstituted-2-alkoxyimidazolium salts with hydrides and/or hydride donors

Preparing imidazolium salts, preferably 1,3-disubstiuted imidazolium salts, useful e.g. as precursors of N-heterocyclic carbenes, comprises reducing 1,3-disubstituted-2-alkoxyimidazolium salts with hydrides and/or hydride donors

机译:制备咪唑鎓盐,优选例如1,3-二取代的咪唑鎓盐。作为N-杂环卡宾的前体,包括与氢化物和/或氢化物供体一起还原1,3-二取代-2-烷氧基咪唑鎓盐

摘要

Preparing imidazolium salts (II) comprises reducing 1,3-disubstituted-2-alkoxyimidazolium salts (I) with hydrides and/or hydride donors. Preparing imidazolium salts of formula (II) comprises reducing 1,3-disubstituted-2-alkoxyimidazolium salts of formula (I) with hydrides and/or hydride donors. Either R1-R5 : H, 1-20C-alkyl, 2-20C-alkenyl with one or more double bonds, 2-20C-alkynyl with one or more triple bonds or optionally partially or completely saturated 3-10C-cycloalkyl (optionally substituted with 1-10C-alkyl); or R1R2, R1R3 or R3R4 bounded by single-, double- or triple-bonds : 3-8-membered ring to form bi-, tri- or poly-cyclic cations, where R1-R5 in any position are partially or completely substituted by halogen (preferably F, Cl, Br or I) or in any position is partially substituted by CN or NO 2, a carbon atom of one or more substituents of R1-R5 is optionally substituted by atom and/or atom groups comprising -O-, -C(O)-, -C(O)O-, -S-, -S(O)-, -SO 2-, -SO 3-, -N=, -N=N-, -NH-, -NR1a-, -PR1a-, -P(O)R1a, -P(O)R1a-O-, -O-P(O)R1a-O- or -P(R1a) 2=N-, and R1a is not fluorinated, partially or perfluorinated 1-6C-alkyl, saturated or partially unsaturated 3-7C-cycloalkyl, optionally substituted phenyl or optionally substituted heterocycle; A -F -, Cl -, Br -, I -, CN -, [ClO 4] -, [BF 4] -, [BF zR(f) 4 - z] -, [BF z(CN) 4 - z] -, [B(CN) 4] -, [B(C 6F 5) 4] -, [B(OR6) 4] -, [N(CF 3) 2] -, [N(CN) 2] -, [AlCl 4] -, [SbF 6] -, [SiF 6] -, [R6SO 3] -, [R(f)SO 3] -, [(R(f)SO 2) 2N] -, [(R(f)SO 2) 3C] -, [(FSO 2) 3C] -, [R6CH 2OSO 3] -, [R6C(O)O] -, [R(f)C(O)O] -, [CCl 3C(O)O] -, [(CN) 3C] -, [(CN) 2CR6] -, [(R6O(O)C) 2CR6] -, [P(C nF 2 n + 1 - mH m) yF 6 - y] -, [P(C 6F) yF 6 - y] -, [R6 2P(O)O] -, [R6P(O)O 2] 2 -, [(R6O) 2P(O)O] -, [(R6O)P(O)O 2] 2 -, [(R6O)(R6)P(O)O] -, [R(f) 2P(O)O] -or [R(f)P(O)O 2] 2 -, where A -contains at least two substituents R(f), and at least two R6, in which R(f) are bounded together by single or double bonds to form 3-8 membered ring, and R6 are bounded together by single or double bonds to form 3-8 membered ring; R(f) : perfluorinated and optionally branched 1-20C-alkyl, perfluorinated and optionally branched 2-20C-alkenyl with one or more double bonds, perfluorinated phenyl and optionally partially or completely saturated 3-7C-cycloalkyl, which is optionally substituted by perfluoroalkyl, where a carbon atom or two non-adjacent carbon atoms of R(f) are optionally substituted by atoms and/or atom groups comprising -O-,-C(O)-, -S-,-S(O)-,-SO 2-, -N=, -N=N-,-NR1a-, -PR1a-, -P(O)R1a, R1a-O-SO 2- or R1a-OC(O)-; R6 : H, linear or branched 1-20C-alkyl, 2-20C-alkenyl with one or more double bonds, 2-20C-alkynyl with one or more triple bonds or optionally partially or completely saturated 3-10C-cycloalkyl, which is optionally substituted with 1-10C-alkyl, where R6 is partially substituted by CN -or NO 2-, F -, Cl -, Br -or I -, and a carbon atom of R6 are optionally substituted by atoms and/or atom groups comprising -O-, -C(O)-, -C(O)O-, -S-, -S(O)-, -SO 2-, -SO 3-, -N=, -N=N-, -NH-, -NR1a-, -PR1a- and -P(O)R1a, -P(O)R1a-O- or -O-P(O)R1a-O-, -P(R1a) 2=N-, -C(O)NH-, -C(O)NR1a, -SO 2NH- or -SO 2NR1a-; n : 1-20; m, z : 0-3; and y : 0-4. [Image].
机译:制备咪唑鎓盐(II)包括用氢化物和/或氢化物供体还原1,3-二取代-2-烷氧基咪唑鎓盐(I)。式(II)的咪唑鎓盐的制备包括用氢化物和/或氢化物供体还原式(I)的1,3-二取代-2-烷氧基咪唑鎓盐。 R1-R5:H,具有一个或多个双键的1-20C-烷基,2-20C-烯基,具有一个或多个三键的2-20C-炔基或可选地部分或完全饱和的3-10C-环烷基(可选地被取代) 1-10C-烷基);或通过单键,双键或三键结合的R1R2,R1R3或R3R4:3-8元环形成双环,三环或多环阳离子,其中任何位置的R1-R5被部分或完全取代卤素(优选F,Cl,Br或I)或在任何位置被CN或NO 2部分取代,R 1 -R 5的一个或多个取代基的碳原子任选地被包含-O-的原子和/或原子团取代,-C(O)-,-C(O)O-,-S-,-S(O)-,-SO 2-,-SO 3-,-N =,-N = N-,-NH- ,-NR1a-,-PR1a-,-P(O)R1a,-P(O)R1a-O-,-OP(O)R1a-O-或-P(R1a)2 = N-,而R1a不是氟化的,部分或全氟化的1-6C-烷基,饱和或部分不饱和的3-7C-环烷基,任选取代的苯基或任选取代的杂环; A-> F->,Cl->,Br->,I->,CN->,[ClO 4]->,[BF 4]->,[BF zR(f)4-z]->, [BF z(CN)4-z]->,[B(CN)4]->,[B(C 6F 5)4]->,[B(OR6)4]->,[N(CF 3 )2]->,[N(CN)2]->,[AlCl 4]->,[SbF 6]->,[SiF 6]->,[R6SO 3]->,[R(f)SO 3]->,[(R(f)SO 2)2N]->,[(R(f)SO 2)3C]->,[(FSO 2)3C]->,[R6CH 2OSO 3]-> ,[R6C(O)O]->,[R(f)C(O)O]->,[CCl 3C(O)O]->,[(CN)3C]->,[(CN)2CR6 ]->,[(R6O(O)C 2CR6]->,[P(C nF 2 n +1-mH m)yF 6-y]->,[P(C 6F)yF 6-y]- >,[R6 2P(O)O]->,[R6P(O)O 2] 2>->,[(R6O)2P(O)O]->,[(R6O)P(O)O 2] 2>->,[(R6O)(R6)P(O)O]->,[R(f)2P(O)O]->或[R(f)P(O)O 2] 2>- >,其中A->包含至少两个取代基R(f),和至少两个R6,其中R(f)通过单键或双键结合在一起以形成3-8元环,并且R6通过单键或双键形成3-8元环; R(f):具有一个或多个双键的全氟和任选支链的1-20C-烷基,全氟和任选支链的2-20C-烯基,全氟苯基和任选地部分或完全饱和的3-7C-环烷基,其任选地被取代全氟烷基,其中R(f)的一个碳原子或两个不相邻的碳原子可选地被包含-O-,-C(O)-,-S-,-S(O)-的原子和/或原子团取代-SO 2-,-N =,-N = N-,-NR1a-,-PR1a-,-P(O)R1a,R1a-O-SO 2-或R1a-OC(O)-; R6:H,直链或支链的1-20C-烷基,具有一个或多个双键的2-20C-烯基,具有一个或多个三键或任选地部分或完全饱和的3-10C-环烷基的2-20C-炔基任选地被1-10C-烷基取代,其中R6被CN->或NO 2-,F->,Cl->,Br->或I->部分取代,并且R6的碳原子被原子取代和/或包含-O-,-C(O)-,-C(O)O-,-S-,-S(O)-,-SO 2-,-SO 3-,-N =的原子团, -N = N-,-NH-,-NR1a-,-PR1a-和-P(O)R1a,-P(O)R1a-O-或-OP(O)R1a-O-,-P(R1a) 2 = N-,-C(O)NH-,-C(O)NR1a,-SO 2NH-或-SO 2NR1a-; n:1-20; n:1-20。 m,z:0-3; y:0-4。 [图片]。

著录项

  • 公开/公告号DE102008014028A1

    专利类型

  • 公开/公告日2009-09-17

    原文格式PDF

  • 申请/专利权人 KUNZ DORIS;

    申请/专利号DE20081014028

  • 发明设计人 KUNZ DORIS;DEISLER CHRISTINE;

    申请日2008-03-13

  • 分类号C07D233/54;C07D471/14;

  • 国家 DE

  • 入库时间 2022-08-21 19:09:13

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号